Oryn Therapeutics is Drug Discovery in United States that focus on retro-evolutionary therapies business. Founded in 2013. They cover business area such as developer, synthetic therapeutic cyclic peptide technology, rheumatoid arthritis, drug-resistant infection, naturally-occur endogenous theta-defensin, patient, retro, evolutionary therapy, autoimmune and infectious disease.
2013
( 11 years old in 2024 )
Retro-evolutionary Therapies
-
3333 Vaca Valley Parkway
Suite 400
Vacaville, CA 95688
United States
Private
developersynthetic therapeutic cyclic peptide technologyrheumatoid arthritisdrug-resistant infectionnaturally-occur endogenous theta-defensinpatientretroevolutionary therapyautoimmune and infectious disease
* We use standard office opening hours in near Oryn Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Oryn Therapeutics is Drug Discovery business from United States that founded in 2013 (11 years old in 2024), Oryn Therapeutics business is focusing on Retro-evolutionary Therapies.
Oryn Therapeutics headquarter office and corporate office address is located in 3333 Vaca Valley Parkway Suite 400 Vacaville, CA 95688 United States.
Oryn Therapeutics was founded in United States.
In 2024, Oryn Therapeutics is currently focus on retro-evolutionary therapies sector.
Above is snippet of Google Trends for "retro-evolutionary therapies" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Oryn Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
